Open letter to Bristol Myers Squibb: Belatacept; we aren't done yet

Am J Transplant. 2023 Oct;23(10):1483-1484. doi: 10.1016/j.ajt.2023.05.033. Epub 2023 Jun 9.
No abstract available

Keywords: Transplant; belatacept; costimulation.

Publication types

  • Editorial

MeSH terms

  • Abatacept / therapeutic use
  • Immunosuppressive Agents* / therapeutic use
  • Kidney Transplantation*

Substances

  • Abatacept
  • Immunosuppressive Agents